Postoperative Complications After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Affect Long-term Outcome of Patients With Peritoneal Metastases From Colorectal Cancer-Reference-Cited by-同舟云学术

Postoperative Complications After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Affect Long-term Outcome of Patients With Peritoneal Metastases From Colorectal Cancer

Published:2014-07 Issue:7 Volume:57 Page:858-868
ISSN:0012-3706
Container-title:Diseases of the Colon & Rectum
language:en
Short-container-title:

Author:

Baratti D.,Kusamura S.,Iusco D.,Bonomi S.,Grassi A.,Virzì S.,Leo E.,Deraco M.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,General Medicine

Reference38 articles.

1. Peritoneal carcinomatosis from colorectal cancer.;Jayne;Br J Surg,2002

2. Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: a population-based study.;Lemmens;Int J Cancer,2011

3. Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer.;Segelman;Br J Surg,2012

4. Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies.;Koppe;Ann Surg,2006

5. Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study.;Saltz;J Clin Oncol,2008

Cited by 104 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is Hyperthermic Intraperitoneal Chemotherapy Appropriate for Colon Cancer?;Advances in Surgery;2024-09

2. Postoperative Complications Result in Poor Oncological Outcomes: What Is the Evidence?;Current Oncology;2024-08-15

3. The 2022 PSOGI International Consensus on HIPEC Regimens for Peritoneal Malignancies: HIPEC Technologies;Annals of Surgical Oncology;2024-07-22

4. Systemic Chemotherapy in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery: Systematic Review and Meta-Analysis;Cancers;2024-03-18

5. Current clinical practices of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC);Innovative Surgical Sciences;2024-03-01